201 related articles for article (PubMed ID: 18988681)
1. Artemisinin derivatives inhibit Toxoplasma gondii in vitro at multiple steps in the lytic cycle.
D'Angelo JG; Bordón C; Posner GH; Yolken R; Jones-Brando L
J Antimicrob Chemother; 2009 Jan; 63(1):146-50. PubMed ID: 18988681
[TBL] [Abstract][Full Text] [Related]
2. Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain.
Liu S; Wu M; Hua Q; Lu D; Tian Y; Yu H; Cheng L; Chen Y; Cao J; Hu X; Tan F
Parasit Vectors; 2020 May; 13(1):242. PubMed ID: 32393321
[TBL] [Abstract][Full Text] [Related]
3. Thiazole, oxadiazole, and carboxamide derivatives of artemisinin are highly selective and potent inhibitors of Toxoplasma gondii.
Hencken CP; Jones-Brando L; Bordón C; Stohler R; Mott BT; Yolken R; Posner GH; Woodard LE
J Med Chem; 2010 May; 53(9):3594-601. PubMed ID: 20373807
[TBL] [Abstract][Full Text] [Related]
4. In vitro inhibition of Toxoplasma gondii by four new derivatives of artemisinin.
Jones-Brando L; D'Angelo J; Posner GH; Yolken R
Antimicrob Agents Chemother; 2006 Dec; 50(12):4206-8. PubMed ID: 17060514
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of 4-acyl-2-thiazolylhydrazone derivatives for anti-Toxoplasma efficacy in vitro.
Chimenti F; Bizzarri B; Bolasco A; Secci D; Chimenti P; Carradori S; Granese A; Rivanera D; Frishberg N; Bordón C; Jones-Brando L
J Med Chem; 2009 Aug; 52(15):4574-7. PubMed ID: 19618935
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of anti-Toxoplasma gondii activity of a novel scaffold of thiazolidinone derivatives.
Carradori S; Secci D; Bizzarri B; Chimenti P; De Monte C; Guglielmi P; Campestre C; Rivanera D; Bordón C; Jones-Brando L
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):746-758. PubMed ID: 28537532
[TBL] [Abstract][Full Text] [Related]
7. 1,3,4-Thiadiazoles Effectively Inhibit Proliferation of
Węglińska L; Bekier A; Dzitko K; Pacholczyk-Sienicka B; Albrecht Ł; Plech T; Paneth P; Paneth A
Cells; 2021 Apr; 10(5):. PubMed ID: 33946881
[TBL] [Abstract][Full Text] [Related]
8. Hydroxylamine and Carboxymethoxylamine Can Inhibit
Li J; Guo H; Galon EM; Gao Y; Lee SH; Liu M; Li Y; Ji S; Jia H; Xuan X
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31907178
[No Abstract] [Full Text] [Related]
9. Host cells participate in the in vitro effects of novel diamidine analogues against tachyzoites of the intracellular apicomplexan parasites Neospora caninum and Toxoplasma gondii.
Leepin A; Stüdli A; Brun R; Stephens CE; Boykin DW; Hemphill A
Antimicrob Agents Chemother; 2008 Jun; 52(6):1999-2008. PubMed ID: 18362190
[TBL] [Abstract][Full Text] [Related]
10. Auranofin is highly efficacious against Toxoplasma gondii in vitro and in an in vivo experimental model of acute toxoplasmosis.
Andrade RM; Chaparro JD; Capparelli E; Reed SL
PLoS Negl Trop Dis; 2014; 8(7):e2973. PubMed ID: 25079790
[TBL] [Abstract][Full Text] [Related]
11. One-pot, multicomponent synthesis of 2,3-disubstituted quinazolin-ones with potent and selective activity against Toxoplasma gondii.
Brown CE; Kong T; Bordón C; Yolken R; Jones-Brando L; McNulty J
Bioorg Med Chem Lett; 2018 May; 28(9):1642-1646. PubMed ID: 29598911
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Toxoplasma gondii and Plasmodium falciparum infections in vitro by NSC3852, a redox active antiproliferative and tumor cell differentiation agent.
Strobl JS; Seibert CW; Li Y; Nagarkatti R; Mitchell SM; Rosypal AC; Rathore D; Lindsay DS
J Parasitol; 2009 Feb; 95(1):215-23. PubMed ID: 18837587
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, in vitro and in vivo biological evaluation of dihydroartemisinin derivatives with potential anti-Toxoplasma gondii agents.
Deng H; Huang X; Jin C; Jin CM; Quan ZS
Bioorg Chem; 2020 Jan; 94():103467. PubMed ID: 31791681
[TBL] [Abstract][Full Text] [Related]
14. A thiazole derivative of artemisinin moderately reduces Toxoplasma gondii cyst burden in infected mice.
Schultz TL; Hencken CP; Woodard LE; Posner GH; Yolken RH; Jones-Brando L; Carruthers VB
J Parasitol; 2014 Aug; 100(4):516-21. PubMed ID: 24524228
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological characterization of thiazolidin-4-one derivatives as promising inhibitors of Toxoplasma gondii.
D'Ascenzio M; Bizzarri B; De Monte C; Carradori S; Bolasco A; Secci D; Rivanera D; Faulhaber N; Bordón C; Jones-Brando L
Eur J Med Chem; 2014 Oct; 86():17-30. PubMed ID: 25140751
[TBL] [Abstract][Full Text] [Related]
16. Licochalcone A: An effective and low-toxicity compound against Toxoplasma gondii in vitro and in vivo.
Si H; Xu C; Zhang J; Zhang X; Li B; Zhou X; Zhang J
Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):238-245. PubMed ID: 29684680
[TBL] [Abstract][Full Text] [Related]
17. Toxoplasma gondii: inhibitory activity and encystation effect of securinine and pyrrolidine derivatives on Toxoplasma growth.
Holmes M; Crater AK; Dhudshia B; Thadani AN; Ananvoranich S
Exp Parasitol; 2011 Feb; 127(2):370-5. PubMed ID: 20833168
[TBL] [Abstract][Full Text] [Related]
18. In vitro effects of new artemisinin derivatives in Neospora caninum-infected human fibroblasts.
Müller J; Balmer V; Winzer P; Rahman M; Manser V; Haynes RK; Hemphill A
Int J Antimicrob Agents; 2015 Jul; 46(1):88-93. PubMed ID: 25934265
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of Toxoplasma gondii and Plasmodium falciparum by nanomolar concentrations of 1-hydroxy-2-dodecyl-4(1H)quinolone, a high-affinity inhibitor of alternative (type II) NADH dehydrogenases.
Saleh A; Friesen J; Baumeister S; Gross U; Bohne W
Antimicrob Agents Chemother; 2007 Apr; 51(4):1217-22. PubMed ID: 17242151
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of N-phenyl-1,10-phenanthroline-2-amines against tachyzoites and bradyzoites of Toxoplasma gondii.
Martins-Duarte ES; Portes JA; da Silva RB; Pires HS; Garden SJ; de Souza W
Bioorg Med Chem; 2021 Nov; 50():116467. PubMed ID: 34666274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
